Skip to main content
SpringerLink
Log in

Transplantation of the Sensitized Patient: Histocompatibility Testing

  • Protocol
  • First Online:
Transplantation Immunology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1034))

Abstract

A component necessary for successful transplantation of the sensitized patient is timely and high quality support from the histocompatibility laboratory that helps guide selection of the best route to transplantation and the clinical care of the patient. Responsibilities of the laboratory include risk assessment, HLA typing, and accurate antibody characterization.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Montgomery RA, Lonze BE, Jackson AM (2011) Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. Curr Opin Organ Transplant 16:439–443

    Article  PubMed  CAS  Google Scholar 

  2. Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH et al (2008) Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359:242–251

    Article  PubMed  CAS  Google Scholar 

  3. Lai CH, Cao K, Ong G, Naim M, Wang Q, Mirocha J et al (2011) Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy. Transplantation 92:48–53

    Article  PubMed  CAS  Google Scholar 

  4. Alachkar N, Lonze BE, Zachary AA, Holechek MJ, Schillinger K, Cameron AM et al (2012) Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation 94:165–171

    Article  PubMed  CAS  Google Scholar 

  5. Montgomery RA, Zachary AA (2004) Transplanting patients with a positive donor-specific crossmatch: a single center’s perspective. Pediatr Transplant 8:535–542

    Article  PubMed  Google Scholar 

  6. Zachary AA, Montgomery RA, Ratner LE, Samaniego-Picota M, Haas M, Kopchaliiska D et al (2003) Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 76:1519–1525

    Article  PubMed  CAS  Google Scholar 

  7. Zachary AA, Montgomery RA, Leffell MS (2005) Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Hum Immunol 66:364–370

    Article  PubMed  CAS  Google Scholar 

  8. Zachary AA, Sholander JT, Houp JA, Leffell MS (2009) Using real data for a virtual crossmatch. Hum Immunol 70:574–579

    Article  PubMed  CAS  Google Scholar 

  9. Ferrari P, Fidler S, Holdsworth R, Woodroffe C, Tassone G, Watson N, Cantwell L, Bennett G, Thornton A, Christiansen FT, D’Orsogna L (2012) High transplant rates of highly sensitized recipients with virtual crossmatching in kidney paired donation. Transplantation 94:744–749

    Article  PubMed  Google Scholar 

  10. Ellis TM, Schiller JJ, Roza AM, Cronin DC, Shames BD, Johnson CP (2012) Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength. Hum Immunol 73:706–710

    Article  PubMed  CAS  Google Scholar 

  11. Tait BD (2009) Solid phase assays for HLA antibody detection in clinical transplantation. Curr Opin Immunol 21:573–577

    Article  PubMed  CAS  Google Scholar 

  12. Waterboer T, Sehr P, Pawlita M (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309:200–204

    Article  PubMed  CAS  Google Scholar 

  13. Zachary AA, Lucas DP, Detrick B, Leffell MS (2009) Naturally occurring interference in Luminex® assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 70:496–501

    Article  PubMed  CAS  Google Scholar 

  14. Schnaidt M, Weinstock C, Jurisic M, Schmid-Horch B, Ender A, Wernet D (2011) HLA antibody specification using single-antigen beads—technical solution for the prozone effect. Transplantation 92:510–515

    Article  PubMed  CAS  Google Scholar 

  15. Butch AW (2000) Dilution protocols for detection of hook effects/prozone phenomenon. Clin Chem 46:1719

    PubMed  CAS  Google Scholar 

  16. Zachary AA, Vega RM, Lucas DP, Leffell MS (2012) HLA antibody detection and characterization by solid phase immunoassays: methods and pitfalls. Methods Mol Biol 882:289–308

    Article  PubMed  CAS  Google Scholar 

  17. Jackson AM, Leffell MS, Montgomery RA, Zachary AA (2012) A GPS for finding the route to transplantation of the sensitized patient. Curr Opin Organ Transplant 17:433–439

    Article  PubMed  Google Scholar 

  18. Montgomery RA (2010) Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 10:449–457

    Article  PubMed  CAS  Google Scholar 

  19. Zachary AA, Montgomery RA, Jordan SC, Reinsmoen NL, Claas FHJ, Reed EF (2007) 14th International HLA and immunogenetics workshop: report on understanding antibodies in transplantation. Tissue Antigens 69(S1):160–173

    Article  PubMed  Google Scholar 

  20. Zachary A, Reinsmoen NL (2011) Quantifying HLA-specific antibodies in patients undergoing desensitization. Curr Opin Organ Transplant 16:410–415

    Article  PubMed  CAS  Google Scholar 

  21. Reinsmoen NL, Lai CH, Vo A, Cao K, Ong G, Naim M et al (2008) Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 86:820–825

    Article  PubMed  CAS  Google Scholar 

  22. Cecka JM, Terasaki PI (1994) Repeating HLA antigen mismatches in renal transplants—a second class mistake? Transplantation 57:515–519

    PubMed  CAS  Google Scholar 

  23. Opelz G (1995) Repeated HLA mismatches increase the failure rate of second kidney transplants. Collaborative Transplant Study. Transplant Proc 27:658–659

    PubMed  CAS  Google Scholar 

  24. Claas FHJ, Dankers MK, Oudshoorn M, van Rood JJ, Mulder A, Roelen D et al (2005) Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl Immunol 14:187–191

    Article  PubMed  CAS  Google Scholar 

  25. Wissing KM, Fomegné G, Broeders N, Ghisdal L, Hoang AD, Mikhalski D et al (2008) HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies. Transplantation 85:411–416

    PubMed  CAS  Google Scholar 

  26. Duquesnoy RJ (2011) Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity. Front Immunol 2:106

    Article  Google Scholar 

  27. Tambur AR, Leventhal JR, Friedewald JJ, Ramon DS (2010) The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. Transplantation 90:1117–1124

    Article  PubMed  Google Scholar 

  28. Deng CT, El-Awar N, Ozawa M, Cai J, Lachmann N, Terasaki PI (2008) Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients. Transplantation 86:452–459

    Article  PubMed  CAS  Google Scholar 

  29. Zachary AA, Kopchaliiska D, Montgomery RA, Leffell MS (2007) HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation 83:982–988

    Article  PubMed  Google Scholar 

  30. Zachary AA, Kopchaliiska D, Montgomery RA, Melancon JK, Leffell MS (2007) HLA-specific B cells: II. Application to transplantation. Transplantation 83:989–994

    Article  PubMed  Google Scholar 

  31. Zachary AA, Lucas DP, Montgomery RA, Leffell MS (2013) Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA. Transplantation 95(5):701–704

    Article  PubMed  CAS  Google Scholar 

  32. Locke JE, Zachary AA, Warren DS, Segev DL, Houp JA, Montgomery RA, Leffell MS (2009) Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant 9:2136–2139

    Article  PubMed  CAS  Google Scholar 

  33. Mohamed MA, Muth B, Vidyasagar V, Foley D, Fernandez L, Hofmann RM et al (2011) Post-transplant DSA monitoring may predict antibody-mediated rejection in sensitized kidney transplant recipients. Clin Transpl 2011:389–394

    Google Scholar 

  34. Leffell MS, Zachary AA (2010) Antiallograft antibodies: relevance, detection, and monitoring. Curr Opin Organ Transplant 15:2–7

    Article  PubMed  Google Scholar 

  35. Dragun D, Philippe A, Catar R (2012) Role of non-HLA antibodies in organ transplantation. Curr Opin Organ Transplant 17:440–445

    Article  PubMed  CAS  Google Scholar 

  36. Jackson AM, Lucas DP, Melancon JK, Desai NM (2011) Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. Transplantation 92:54–60

    Article  PubMed  CAS  Google Scholar 

  37. Li L, Sigdel T, Vitalone M, Lee SH, Sarwal M (2010) Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation. J Proteome Res 9:6715–6721

    Article  PubMed  CAS  Google Scholar 

  38. Zhang Q, Reed EF (2010) Non-MHC antigenic targets of the humoral response in transplantation. Curr Opin Immunol 22:682–688

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Robert A. Montgomery

  2. Immunogenetics Laboratory, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Mary S. Leffell & Andrea A. Zachary

Authors
  1. Robert A. Montgomery
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary S. Leffell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea A. Zachary
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Immunogenetics Laboratory, Johns Hopkins University School of Medic, E. Monument Street 2041, Baltimore, 21205, Maryland, USA

    Andrea A. Zachary

  2. , Immunogenetics Laboratory, Johns Hopkins University School of Medic, E. Monument Street 2041, Baltimore, 21205, Maryland, USA

    Mary S. Leffell

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Montgomery, R.A., Leffell, M.S., Zachary, A.A. (2013). Transplantation of the Sensitized Patient: Histocompatibility Testing. In: Zachary, A., Leffell, M. (eds) Transplantation Immunology. Methods in Molecular Biology, vol 1034. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-493-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-493-7_6

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-492-0

  • Online ISBN: 978-1-62703-493-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation